Does ENASIDENIB Cause Differentiation syndrome? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Differentiation syndrome have been filed in association with ENASIDENIB (Idhifa). This represents 2.8% of all adverse event reports for ENASIDENIB.
102
Reports of Differentiation syndrome with ENASIDENIB
2.8%
of all ENASIDENIB reports
19
Deaths
66
Hospitalizations
How Dangerous Is Differentiation syndrome From ENASIDENIB?
Of the 102 reports, 19 (18.6%) resulted in death, 66 (64.7%) required hospitalization, and 11 (10.8%) were considered life-threatening.
Is Differentiation syndrome Listed in the Official Label?
Yes, Differentiation syndrome is listed as a known adverse reaction in the official FDA drug label for ENASIDENIB.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Off label use (213)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Decreased appetite (122)
Platelet count decreased (113)
Drug ineffective (108)
What Other Drugs Cause Differentiation syndrome?
TRETINOIN (251)
ARSENIC TRIOXIDE (180)
GILTERITINIB (80)
IVOSIDENIB (80)
AZACITIDINE (50)
HYDROXYUREA (41)
DEXAMETHASONE (38)
CYTARABINE (33)
PREDNISONE (25)
PIPERACILLIN\TAZOBACTAM (24)
Which ENASIDENIB Alternatives Have Lower Differentiation syndrome Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ